share

Cdk9-Protac CAS NO 2118356-96-8


Unit Price:

CAS No.:2118356-96-8

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Cdk9-Protac CAS NO 2118356-96-8 is a potent and selective proteolysis-targeting chimera (PROTAC) molecule designed to induce the degradation of Cyclin-dependent kinase 9 (CDK9). This compound matters as a cutting-edge chemical probe and research tool for investigating CDK9's role in transcription regulation, cell cycle control, and disease pathways, particularly in oncology. It is primarily needed by pharmaceutical R&D teams, academic researchers, and biotechnology companies focused on targeted protein degradation (TPD) strategies, cancer biology, and the development of novel therapeutic modalities.

Application

  • Targeted Protein Degradation Research: Serves as a key chemical tool for validating the PROTAC mechanism and studying CDK9 biology in cellular and in vivo models.
  • Oncology and Cancer Biology Studies: Used to investigate the therapeutic potential of CDK9 degradation in various cancer cell lines, including those dependent on transcriptional addiction (e.g., MYC-driven cancers).
  • Drug Discovery & Preclinical Development: Acts as a lead compound or reference standard for designing and optimizing next-generation CDK9 degraders.
  • Transcriptional Regulation Analysis: Enables research into the effects of rapid CDK9 removal on RNA polymerase II phosphorylation and gene expression profiles.
  • Chemical Biology & Proteomics: Utilized in mechanistic studies to understand ternary complex formation, ubiquitin-proteasome system engagement, and kinome-wide selectivity.
  • Virology Research: Applied in studies exploring host dependency factors, such as CDK9, for viral replication (e.g., HIV).

Basic Information

Product Name Cdk9-Protac
CAS No. 2118356-96-8
Molecular Formula C₄₀H₄₇ClN₈O₇
Molecular Weight 763.31 g/mol
Synonyms THAL-SNS-032; CDK9 degrader; PROTAC CDK9 Degrader-1; (S,R,S)-AHPC-CDK9 ligand; CDK9-PROTAC; (S,R,S)-AHPC-MeTrazine-CDK9 ligand; BMS Analog for CDK9 Degradation; CDK9 Targeting PROTAC
EINECS Contact for details

Quality Control

Our Cdk9-Protac is produced under strict quality management protocols to ensure batch-to-batch consistency and high purity, essential for sensitive biological research. Each lot undergoes comprehensive analytical characterization, including HPLC, NMR, and mass spectrometry. A Certificate of Analysis (COA) detailing purity, identity, and potency is provided with every shipment to support your research and regulatory documentation needs.

Storage

Preserve in a tightly closed container, protected from light. For long-term stability, store desiccated at -20°C. Allow the product to equilibrate to room temperature before opening to minimize moisture condensation. This compound is intended for research use only in a laboratory setting.

Specification

Item Specification
Appearance White to off-white solid
Identification (HPLC) Retention time corresponds to reference standard
Identification (MS) Consistent with molecular weight
Purity (HPLC) ≥95%
Water Content (KF) ≤1.0%
Solubility Soluble in DMSO, DMF; sparingly soluble in ethanol

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.